We are pleased to welcome Erik Sandberg to the board of Welldium, where he joins on behalf of KRING Speedbooting 2019.
For a number of years, Erik was CEO of Orifarm, one of Denmark's largest pharmaceutical companies, which grew to more than €2 billion in revenue under his leadership through an ambitious acquisition and growth strategy. That is exactly the experience of building, integrating and scaling a healthcare company that Welldium can draw on now.
Experience and his own capital
We are particularly pleased with Erik's personal commitment. He has invested both in KRING Speedbooting 2019 and, later, directly in Welldium as part of its ongoing capital raise.
When a profile like Erik joins with both his experience and his own capital, it is a strong signal of belief in the case.
About Welldium
Founded in 2021, Welldium has become the leading B2B2C platform for professional supplements in the EU. Healthcare practitioners build treatment protocols from the platform's catalogue, their patients order directly, and Welldium fulfils the orders from its warehouse in Venlo in the Netherlands.
More than 6,500 practitioners are registered on the platform, which carries 125+ brands and 3,500+ products. Welldium grows through a buy-and-build strategy, acquiring traditional supplement distributors and moving their practitioner networks onto the platform. After proving the model in the DACH region, Welldium closed its first UK acquisition this year and is now entering the UK market.
Pictured: Erik Sandberg and Lars Monrad-Gylling (board, KRING Speedbooting 2019) with Martin Kring and Jesper Kring.
Learn more at welldium.com.
